Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

IgG-switched CLL has a distinct immunogenetic signature from the common MD variant: ontogenetic implications

A. Vardi, A. Agathangelidis, LA. Sutton, M. Chatzouli, L. Scarfò, L. Mansouri, V. Douka, A. Anagnostopoulos, N. Darzentas, R. Rosenquist, P. Ghia, C. Belessi, K. Stamatopoulos,

. 2014 ; 20 (2) : 323-30.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14074509

PURPOSE: Immunoglobulin G-switched chronic lymphocytic leukemia (G-CLL) is a rare variant of CLL, whose origin and ontogenetic relationship to the common IgM/IgD (MD-CLL) variant remains undefined. Here, we sought for clues about the ontogeny of G-CLL versus MD-CLL by profiling the relevant IG gene repertoires. EXPERIMENTAL DESIGN: Using purpose-built bioinformatics methods, we performed detailed immunogenetic profiling of a multinational CLL cohort comprising 1,256 cases, of which 1,087 and 169 expressed IG mu/delta and gamma heavy chains, respectively. RESULTS: G-CLL has a highly skewed IG gene repertoire that is distinct from MD-CLL, especially in terms of (i) overuse of the IGHV4-34 and IGHV4-39 genes and (ii) differential somatic hypermutation (SHM) load. Repertoire differences were also found when comparing subgroups with similar SHM status and were mainly attributed to the exclusive representation in G-CLL of two major subsets with quasi-identical (stereotyped) B-cell receptors. These subsets, namely #4 (IGHV4-34/IGKV2-30) and #8 (IGHV4-39/IGKV1(D)-39), were found to display sharply contrasting SHM and clinical behavior. CONCLUSIONS: G-CLL exhibits an overall distinct immunogenetic signature from MD-CLL, prompting speculations about distinct ontogenetic derivation and/or immune triggering. The reasons underlying the differential regulation of SHM among G-CLL cases remain to be elucidated.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14074509
003      
CZ-PrNML
005      
20141007120700.0
007      
ta
008      
141006s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1158/1078-0432.CCR-13-1993 $2 doi
035    __
$a (PubMed)24240110
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Vardi, Anna $u Authors' Affiliations: Hematology Department and HCT Unit, G. Papanicolaou Hospital; Institute of Applied Biosciences, Centre for Research & Technology Hellas, Thessaloniki, Greece; Division of Molecular Oncology, San Raffaele Scientific Institute, Milan, Italy; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; Hematology Department, Nikea General Hospital, Piraeus, Greece; and Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
245    10
$a IgG-switched CLL has a distinct immunogenetic signature from the common MD variant: ontogenetic implications / $c A. Vardi, A. Agathangelidis, LA. Sutton, M. Chatzouli, L. Scarfò, L. Mansouri, V. Douka, A. Anagnostopoulos, N. Darzentas, R. Rosenquist, P. Ghia, C. Belessi, K. Stamatopoulos,
520    9_
$a PURPOSE: Immunoglobulin G-switched chronic lymphocytic leukemia (G-CLL) is a rare variant of CLL, whose origin and ontogenetic relationship to the common IgM/IgD (MD-CLL) variant remains undefined. Here, we sought for clues about the ontogeny of G-CLL versus MD-CLL by profiling the relevant IG gene repertoires. EXPERIMENTAL DESIGN: Using purpose-built bioinformatics methods, we performed detailed immunogenetic profiling of a multinational CLL cohort comprising 1,256 cases, of which 1,087 and 169 expressed IG mu/delta and gamma heavy chains, respectively. RESULTS: G-CLL has a highly skewed IG gene repertoire that is distinct from MD-CLL, especially in terms of (i) overuse of the IGHV4-34 and IGHV4-39 genes and (ii) differential somatic hypermutation (SHM) load. Repertoire differences were also found when comparing subgroups with similar SHM status and were mainly attributed to the exclusive representation in G-CLL of two major subsets with quasi-identical (stereotyped) B-cell receptors. These subsets, namely #4 (IGHV4-34/IGKV2-30) and #8 (IGHV4-39/IGKV1(D)-39), were found to display sharply contrasting SHM and clinical behavior. CONCLUSIONS: G-CLL exhibits an overall distinct immunogenetic signature from MD-CLL, prompting speculations about distinct ontogenetic derivation and/or immune triggering. The reasons underlying the differential regulation of SHM among G-CLL cases remain to be elucidated.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genová přestavba B-lymfocytů $7 D015322
650    _2
$a lidé $7 D006801
650    _2
$a imunogenetika $7 D007125
650    _2
$a imunoglobulin D $x genetika $7 D007072
650    _2
$a imunoglobulin G $x genetika $7 D007074
650    _2
$a těžké řetězce imunoglobulinů $x genetika $7 D007143
650    _2
$a imunoglobulin M $x genetika $7 D007075
650    _2
$a variabilní oblast imunoglobulinu $x genetika $7 D007135
650    _2
$a chronická lymfatická leukemie $x genetika $x imunologie $7 D015451
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a receptory antigenů B-buněk $x klasifikace $x genetika $7 D011947
650    _2
$a somatická hypermutace imunoglobulinových genů $7 D027041
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Agathangelidis, Andreas $7 gn_A_00002103
700    1_
$a Sutton, Lesley-Ann
700    1_
$a Chatzouli, Maria
700    1_
$a Scarfò, Lydia
700    1_
$a Mansouri, Larry
700    1_
$a Douka, Vassiliki
700    1_
$a Anagnostopoulos, Achilles $7 gn_A_00005807
700    1_
$a Darzentas, Nikos
700    1_
$a Rosenquist, Richard
700    1_
$a Ghia, Paolo
700    1_
$a Belessi, Chrysoula
700    1_
$a Stamatopoulos, Kostas
773    0_
$w MED00001121 $t Clinical cancer research : an official journal of the American Association for Cancer Research $x 1078-0432 $g Roč. 20, č. 2 (2014), s. 323-30
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24240110 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20141006 $b ABA008
991    __
$a 20141007121137 $b ABA008
999    __
$a ok $b bmc $g 1042392 $s 873421
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 20 $c 2 $d 323-30 $i 1078-0432 $m Clinical cancer research $n Clin Cancer Res $x MED00001121
LZP    __
$a Pubmed-20141006

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...